Xospata (gilteritinib) is a prescription medicine used to treat acute myeloid leukemia (AML) in adults with an abnormal FLT3 gene. Your doctor will test you for this gene. Xospata is given after other cancer treatments did not work or have stopped working.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of XOSPATA (gilteritinib) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the XOSPATA (gilteritinib) tablets medicine cost price in India.
The order for XOSPATA (gilteritinib) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Gilteritinib (trade name Xospata) is an anti-cancer drug. It acts as an inhibitor of AXL receptor tyrosine kinase, hence it is a tyrosine kinase inhibitor.
XOSPATA (gilteritinib) tablets for oral use Initial U.S. Approval: 2001
Generic Name: gilteritinib
Tablets : 40 mg.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand XOSPATA (gilteritinib) tablets on prescription and Import License in Patient's Name only.
For overseas patients, XOSPATA (gilteritinib) tablets can be made available in Send your enquiry to find XOSPATA (gilteritinib) tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For XOSPATA (gilteritinib) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Lupin in alliance with Natco receives FDA approval for gilteritinib Tablets For More Details
First Generic Version of XOSPATA Approved by FDA For More Details